Clinical advances in antibody-drug conjugates for hematological malignancies by TANG Sijie, MI Jianqing

Subjects: “…antibody-drug conjugate (adc)…”
Get full text

Progresses in research and development of antibody-drug conjugate by Wu Gang, Fu Zhihao, Xu Gangling, Wang Wenbo, Yu Chuanfei, Wang Lan, Wang Junzhi

Subjects: “…antibody-drug conjugate(adc)…”
Get full text

Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo Performance by Nick Evans, Ruslan Grygorash, Paul Williams, Andrew Kyle, Terrence Kantner, Ravindra Pathak, XiaoBo Sheng, Fabio Simoes, Hiteshri Makwana, Ricardo Resende, Elena de Juan, Alan Jenkins, David Morris, Aurelie Michelet, Frances Jewitt, Felicity Rudge, Nicolas Camper, Anaïs Manin, William McDowell, Martin Pabst, Antony Godwin, Mark Frigerio, Matthew Bird

Subjects: “…antibody drug conjugate (ADC)…”
Get full text

From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds by Rita De Sanctis, Rita De Sanctis, Flavia Jacobs, Flavia Jacobs, Chiara Benvenuti, Chiara Benvenuti, Mariangela Gaudio, Mariangela Gaudio, Raul Franceschini, Richard Tancredi, Paolo Pedrazzoli, Paolo Pedrazzoli, Armando Santoro, Armando Santoro, Alberto Zambelli, Alberto Zambelli

Subjects: Get full text

Antibody-drug conjugates: the paradigm shifts in the targeted cancer therapy by Devesh Aggarwal, Jie Yang, Md. Abdus Salam, Sagnik Sengupta, Md. Yusuf Al-Amin, Md. Yusuf Al-Amin, Saad Mustafa, Mohammad Aasif Khan, Xun Huang, Jogendra Singh Pawar, Jogendra Singh Pawar

Subjects: “…Antibody-drug conjugate (ADC)…”
Get full text

Antibody-drug conjugates and predictive biomarkers in advanced urothelial carcinoma by Sarah E. Fenton, Sarah E. Fenton, David J. VanderWeele, David J. VanderWeele

Subjects: Get full text

Therapeutic antibodies for the prevention and treatment of cancer by Mukesh Kumar, Akansha Jalota, Sushil Kumar Sahu, Shabirul Haque

Subjects: Get full text

Opportunities for predictive proteogenomic biomarkers of drug treatment sensitivity in epithelial ovarian cancer by Trudy J. Philips, Britt K. Erickson, Stefani N. Thomas

Subjects: Get full text

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38... by Emanuele Perrone, Emanuele Perrone, Salvatore Lopez, Salvatore Lopez, Burak Zeybek, Stefania Bellone, Elena Bonazzoli, Silvia Pelligra, Luca Zammataro, Aranzazu Manzano, Paola Manara, Anna Bianchi, Natalia Buza, Joan Tymon-Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Pei Hui, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin

Subjects: Get full text

Business Risk Mitigation in the Development Process of New Monoclonal Antibody Drug Conjugates for Cancer Treatment by Balázs Kiss, János Borbély

Subjects: “…antibody–drug conjugate (ADC)…”
Get full text

Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy by Shabnam Malik, Mohammed Sikander, Natasha Bell, Daniel Zubieta, Maria C. Bell, Murali M. Yallapu, Subhash C. Chauhan

Subjects: Get full text

Current LC-MS-based strategies for characterization and quantification of antibody-drug conjugates by Xiaoyu Zhu, Shihan Huo, Chao Xue, Bo An, Jun Qu

Subjects: “…Antibody-drug conjugate (ADC)…”
Get full text

Somatic alterations of TP53 and MDM2 associated with response to enfortumab vedotin in patients with advanced urothelial cancer by Tanya Jindal, Xiaolin Zhu, Rohit Bose, Vipul Kumar, Edward Maldonado, Prianka Deshmukh, Chase Shipp, Stephanie Feng, Michelle S. Johnson, Austin Angelidakis, Daniel Kwon, Hala T. Borno, Ivan de Kouchkovsky, Arpita Desai, Rahul Aggarwal, Lawrence Fong, Eric J. Small, Anthony Wong, Sima Porten, Jonathan Chou, Terence Friedlander, Vadim S. Koshkin

Subjects: Get full text

Six events that shaped antibody approvals in oncology by Suman Paul, Suman Paul, Shibin Zhou, Shibin Zhou

Subjects: Get full text

Physicochemical and biological impact of metal-catalyzed oxidation of IgG1 monoclonal antibodies and antibody-drug conjugates via reactive oxygen species by Zephania Kwong Glover, Aaron Wecksler, Baikuntha Aryal, Shrenik Mehta, Melissa Pegues, Wayman Chan, Mari Lehtimaki, Allen Luo, Alavattam Sreedhara, V. Ashutosh Rao

Subjects: Get full text

Targeting cancer with antibody-drug conjugates: Promises and challenges by Alexis Q. Dean, Shen Luo, Julianne D. Twomey, Baolin Zhang

Subjects: “…Antibody–drug conjugate (adc)…”
Get full text

Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer by Frances Chow, François Lamoureux, Gatien Moriceau

Subjects: Get full text

Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX by Anne E.G. Lenferink, Paul C. McDonald, Christiane Cantin, Suzanne Grothé, Mylene Gosselin, Jason Baardsnes, Myriam Banville, Paul Lachance, Alma Robert, Yuneivy Cepero-Donates, Stevo Radinovic, Patrick Salois, Marie Parat, Hafida Oamari, Annie Dulude, Mehul Patel, Martin Lafrance, Andrea Acel, Nathalie Bousquet-Gagnon, Denis L’Abbé, Alex Pelletier, Félix Malenfant, Maria Jaramillo, Maureen O’Connor-Mccourt, Cunle Wu, Yves Durocher, Mélanie Duchesne, Christine Gadoury, Anne Marcil, Yves Fortin, Beatrice Paul-Roc, Maurizio Acchione, Shawn C. Chafe, Oksana Nemirovsky, Joseph Lau, Francois Bénard, Shoukat Dedhar

Subjects: Get full text

Use of a charge reducing agent to enable intact mass analysis of cysteine-linked antibody-drug-conjugates by native mass spectrometry by Kamila J. Pacholarz, Perdita E. Barran

Subjects: “…Antibody Drug Conjugate (ADC)…”
Get full text

Kinetic models towards an enhanced understanding of diverse ADC conjugation reactions by Jan Tobias Weggen, Ryan Bean, Kimberly Hui, Michaela Wendeler, Jürgen Hubbuch

Subjects: “…antibody-drug conjugate (ADC)…”
Get full text